The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

STRO FINANCIAL STATEMENTS

Sutro Biopharma — balance sheet, income statement and cash flow trends

STROSutro Biopharma

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue45.7 M $Gross Profit44.4 M $ · 97%Operating Income-141.6 M $ · -310%Pre-tax Income-180.7 M $ · -395%Net Income to Owners-180.6 M $ · -395%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue45.7 M $-56.3%
Gross Profit44.4 M $-57.5%
Operating Income-141.6 M $—
EBITDA-134.6 M $—
Net Income to Owners-180.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets194.5 M
  • Current Liabilities6.5 M $2%
  • Long-term Liabilities291.3 M $98%

Key Figures

YoY change
Total Assets194.5 M $-25.9%
Total Liabilities297.8 M $+1.1%
Total Equity-103.3 M $—
Cash & ST Investments164.3 M $-19.9%
Total Debt10.8 M $-95.1%
Net Debt-43.6 M $-128.0%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-145.2 M $Operating32.8 M $Investing102.7 M $Financing-9.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-145.2 M $—
Capital Expenditures446 K $-85.9%
Free Cash Flow-145.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on STRO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.